Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Int J Stroke. 2012 Feb 2;8(5):315–320. doi: 10.1111/j.1747-4949.2011.00754.x

Table 2.

Baseline characteristics: pooled data NEST 1 and NEST 2 by treatment modality

Pooled NEST 1 & 2*
TLT(n=410) Sham (n=368)
Age(y), mean, SD 70.35±12.56 69.72±11.85
Female (%) 184(44.88) 152(41.3)
Time to treatment, mean, SD 15:04±5:45 14:52±6:10
Time to treatment strata < 12 hours 128(31.22) 129(35.05)
Baseline NIHSS score, mean, SD 12.96±4.58 13.04±4.5
Baseline NIHSS score strata, No (%)
Median 12 12
7 to 10 158 (38.54) 151 (41.03)
11 to 15 122 (29.76) 97 (26.36)
16 to 22 130 (31.71) 120 (32.61)
Previous stroke, no (%) 118 (30.24) 121 (32.07)
Diabetes, no (%) 124 (30.24) 118 (32.07)
Hypertension, no (%) 316 (77.07) 294 (79.89)
*

No statistically significant differences were noted in any characteristics between pooled treatment groups by t-test and Fisher exact test as appropriate.

Values are means ± SD and N with percentages in parenthesis.